New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
13:25 EDTJAZZ, JAZZ, JAZZ, SLXP, SLXP, SLXPLeerink's specialty pharma analyst holds analyst/industry conference call
Specialty Pharmaceuticals Analyst Gerberry discusses the prospects for Jazz Pharmaceuticals/Sigma Tau's Defibrotide approval in the U.S., and provides an assessment of challneges facing two key specialty pharma controversies: Defibrotide and Relistor on an Analyst/Industry conference call to be held on February 27 at 2 pm.
News For JAZZ;SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 24, 2015
18:55 EDTJAZZOn The Fly: After Hours Movers
Subscribe for More Information
18:52 EDTJAZZJazz, Celgene, Shire up after USPTO rejects Acorda patent challenge
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use